Gener­ic Adder­all short­ages con­tin­ue as sev­er­al man­u­fac­tur­ers stare down sup­ply squeezes

In ear­ly Au­gust, Te­va hit a bump in pro­duc­ing the pop­u­lar AD­HD drug Adder­all, as the com­pa­ny faced a back­o­rder of the drug in 20 mg and 30 mg tablets, how­ev­er, the sit­u­a­tion has spread to a few oth­er mak­ers of the drug.

Ac­cord­ing to a re­port from the Amer­i­can So­ci­ety of Health-Sys­tem Phar­ma­cists (AH­SP), the short­age has con­tin­ued for Te­va and oth­er man­u­fac­tur­ers, as Am­neal Phar­ma­ceu­ti­cals, Pur­due sub­sidiary Rhodes Phar­ma­ceu­ti­cals and San­doz all face short­ages.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER